| abstract |
The present invention relates to an immunostimulatory agent in hyperthermia for cancer, comprising a heat shock protein-inducing compound such as geranylgeranylacetone. When combined with thermotherapy, the immunostimulatory agent of the present invention can effectively regress tumor tissues that are difficult to treat with hyperthermia alone, and can effectively suppress metastatic cancer, and has few side effects. |